Society Update

New Endocrinology Editor-in-Chief

Andrea C. Gore, Ph.D., is slated to become the next Editor-in-Chief of Endocrinology, from January 2013 through December 2017. She will take over from Jeffrey D. Blaustein, Ph.D. Dr. Gore is currently a member of the The Endocrine Society’s Advocacy and Public Outreach Core Committee.

Dr. Gore is the Gustavus and Louis Pfeiffer Professor of Pharmacology and Toxicology at The University of Texas at Austin. Her research focuses on the neuroendocrine control of reproduction during postnatal development and aging. An internationally recognized expert on the biological actions of endocrine-disrupting chemicals on reproductive development, she is the lead author on the Society’s scientific statement about endocrine-disrupting chemicals. She also served as the basic science chair of the 2007 Annual Meeting Steering Committee.

Society Announces 2012 Harold Vigersky Practicing Physician Travel Award Winner

The Endocrine Society is pleased to announce that the 2012 Harold Vigersky Practicing Physician Travel Award recipient is Michael H. Shanik,
M.D., an endocrinologist practicing at Endocrine Associates of Long Island, P.C., in Smithtown, N.Y. Dr. Shanik attended medical school at New York Medical College and completed his residency at Long Island Jewish Medical Center. He will receive complimentary registration to ENDO 2012 and a $1,500 stipend for travel and lost productivity.

The Harold Vigersky Practicing Physician Travel Award was established by former President Robert Vigersky, M.D., to help clinical practitioners in private practice offset the costs associated with attending ENDO or CEU meetings. Clinical practitioners interested in applying for the 2013 Harold Vigersky Practicing Physician Travel Award can learn more at www. endo-society.org/vigerskyaward.

The Endocrine Society Credit Card

The Endocrine Society has partnered with Capital One® to offer you three credit card options to fit your needs. Choose a card that earns great rewards, one with a low introductory APR, or another to build your credit. Plus, you can choose an image for your card that highlights your support for the Society. Apply today at www.CapitalOneConnect.com/Endo.

New Fact Sheet, Patient Guide from The Hormone Health Network

Neuropathies affect an estimated 60%–70% of patients who have had poorly controlled diabetes for 10 years or more. Most of these patients, however, have a slow progression of symptoms or no symptoms at all, so they may not be aware of a problem until considerable damage has been done. The Hormone Foundation’s latest patient fact sheet, Diabetic Neuropathy, describes the two main nerve disorders caused by diabetes—distal polyneuropathy (DPN) and autonomic neuropathy—and the symptoms and health effects of each. The fact sheet encourages patients to discuss their symptoms with their doctor, get yearly screens for DPN, and pay particular attention to their feet. Patients are assured that they can prevent diabetic neuropathy or slow its progress with good blood glucose control, healthy lifestyle choices, and proper foot care.

Osteoporosis is not just a woman’s disease: About 20% of the 44 million Americans who have osteoporosis or osteopenia are men. The Foundation’s Patient Guide to Osteoporosis in Men is based on The Endocrine Society’s new clinical practice guideline on the same topic. The patient guide defines osteoporosis and identifies its potentially serious consequences. It helps men identify their individual risk factors and describes other diagnostic criteria. The guide explains bone density testing as a tool to detect osteoporosis, and recommends that men at increased risk of osteoporosis, and all men aged 70 years and older, have their bone mineral density measured. Men learn about available treatment options, including medication, and tips on osteoporosis prevention through dietary and lifestyle changes.

Visit www.hormone.org to read and download the fact sheet and patient guide.

Find the Funding You Need

The Society is pleased to announce a new member benefit: EndoGrants Central.

EndoGrants Central is a database of grant opportunities specifically of interest and relevance to the endocrine community, saving you time and effort.

Through EndoGrants Central you can find special, one-time Requests for Proposals (RFPs) from both federal and foundation funders, and opportunities for both U.S. and international researchers. Opportunities are also sorted by eligibility/ career stage: all investigators, earlycareer investigators, and trainees.

The database is updated every Monday so you won’t miss timesensitive RFPs. Learn more at www. endo-society.org/grants.

In Memoriam

Leonard D. Kohn, M.D.
Athens, Ohio
d. April 18, 2012

John C. Lowe, M.A.,
D.C. Houston, Tex.
1946–2012

You may also like

  • New Position Statement Focuses on Patient Experience in Diabetes Care

    Healthcare providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person’s glucose goals. Taking the patient experience into account can improve the quality of care and facilitate attainment of treatment goals, according to a new position statement published in the Endocrine Society’s Journal of Clinical Endocrinology &…

  • Felix Beuschlein Receives 2024 Transatlantic Alliance Award in Endocrinology 

    The Endocrine Society and the European Society of Endocrinology (ESE) are delighted to announce that they have awarded the 2024 Transatlantic Alliance Award to Professor Felix Beuschlein, MD.  Beuschlein is professor of internal medicine/endocrinology and director of the Clinic for Endocrinology, Diabetology, and Clinical Nutrition at the University Clinic Zurich in Switzerland. He received his…

Find more in